275 related articles for article (PubMed ID: 29858008)
1. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease.
Bakuła Z; Kościuch J; Safianowska A; Proboszcz M; Bielecki J; van Ingen J; Krenke R; Jagielski T
Respir Med; 2018 Jun; 139():91-100. PubMed ID: 29858008
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
[TBL] [Abstract][Full Text] [Related]
3. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
[TBL] [Abstract][Full Text] [Related]
4. [Mycobacterium kansasii lung infection].
Lemineur T; Bosquée L
Rev Med Liege; 2015; 70(7-8):395-9. PubMed ID: 26376568
[TBL] [Abstract][Full Text] [Related]
5. [A study on clinical features of Mycobacterium kansasii pulmonary disease in women].
Kamiya H; Ikushima S; Sakamoto T; Morimoto K; Ando T; Oritsu M
Kekkaku; 2008 Feb; 83(2):73-9. PubMed ID: 18326333
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.
Gommans EP; Even P; Linssen CF; van Dessel H; van Haren E; de Vries GJ; Dingemans AM; Kotz D; Rohde GG
Respir Med; 2015 Jan; 109(1):137-45. PubMed ID: 25464905
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.
Moon SM; Park HY; Jeon K; Kim SY; Chung MJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Koh WJ
PLoS One; 2015; 10(10):e0139621. PubMed ID: 26431540
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium kansasii pulmonary diseases in Korea.
Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
[TBL] [Abstract][Full Text] [Related]
10. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.
Cattamanchi A; Nahid P; Marras TK; Gotway MB; Lee TJ; Gonzalez LC; Morris A; Webb WR; Osmond DH; Daley CL
Chest; 2008 Apr; 133(4):875-80. PubMed ID: 18263685
[TBL] [Abstract][Full Text] [Related]
11. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
12. The impact of the 2007 ATS/IDSA diagnostic criteria for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease.
Chae DR; Kim YI; Kee SJ; Kim YH; Chi SY; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim SO; Kim YC; Lim SC
Respiration; 2011; 82(2):124-9. PubMed ID: 20926850
[TBL] [Abstract][Full Text] [Related]
13. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
Shitrit D; Peled N; Bishara J; Priess R; Pitlik S; Samra Z; Kramer MR
Respir Med; 2008 Nov; 102(11):1598-603. PubMed ID: 18619826
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 96 cases with pulmonary disease caused by nontuberculous mycobacteria].
Xia X; Gui X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):239-41. PubMed ID: 11775923
[TBL] [Abstract][Full Text] [Related]
16. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome.
Shitrit D; Priess R; Peled N; Bishara G; Shlomi D; Kramer MR
Eur J Clin Microbiol Infect Dis; 2007 Oct; 26(10):679-84. PubMed ID: 17629758
[TBL] [Abstract][Full Text] [Related]
18. [Three cases of Mycobacterium kansasii pulmonary diseases in previously healthy young women].
Ohnishi T; Kusumoto S; Yamaguchi S; Ohki Y; Satou M; Sugiyama T; Shirai T; Nakashima M; Yamaoka T; Okuda K; Hirose T; Adachi M
Nihon Kokyuki Gakkai Zasshi; 2011 Jun; 49(6):426-31. PubMed ID: 21735743
[TBL] [Abstract][Full Text] [Related]
19. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology.
Corbett EL; Hay M; Churchyard GJ; Herselman P; Clayton T; Williams BG; Hayes R; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 1999 Jun; 3(6):501-7. PubMed ID: 10383063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
